• 2021
    • UBP Yangzhou received Drugs production certificate from NMPA
  • 2020
    • Nov. China NMPA approved the IND of Phase 2 trial in China.
    • Sep. UBP received Certificate of TTQS Enterprise ver. -Silver medal.
    • Aug. UBP Received IND Approval from China NMPA for a Phase 3 Trial
    • Aug. UBP Received Approval from Taiwan FDA for a Phase 1 Trial
    • Apr. UBP Received Approval from TFDA for a Phase 3 Trial
    • Mar. UBP received approval from China NMPA for a phase 1 trial
    • Mar. Received China NMPA Approval for a Phase 2 Trial
    • Jan. UBP received Badge of Accredited Healthy Workplace.
  • 2019
    • Sep. The newly constructed 2,000L commercial scale biologics manufacturing facility in Hukou, Taiwan has been successfully inspected by Taiwan Food and Drug Administration (FDA) and granted with PIC/S GMP certificate.
    • Jun. United BioPharma Receives US FDA Approval for a Phase 2 Trial.
    • May The company received Investigational New Drug (IND) approval from China National Medical Products Administration (NMPA) to conduct a multi-nation, multi-center phase 3 clinical trial.
    • May The company has obtained U.S. FDA’s approval to conduct a clinical trial
  • 2018
    • UBP received an award for its Bioprocess Innovation at the 2018 Asia-Pacific Bioprocess Excellence Award Ceremony.
  • 2017
    • UBP won the Advanced Development of Innovative BioMolecules Award at the 2017 Asia-Pacific Bioprocessing Excellence Forum.
    • UBP received the 2017 “Outstanding Biotechnology Corporation Award” at the BioTaiwan forum.
  • 2016
    • UBP received certificate of occupancy for its eight-story (20,000 sq. meter) headquarter building based in Hukou, Hsinchu county designed for administrative, R&D and large scale protein drug manufacturing activities.
  • 2014
    • UBP won the Gold Medal Prize for Innovative Research and Development given by Taipei City Government in its 2014 Annual Biotechnology Forum for Taipei Biotechnology Award.
    • Establishment of UBP’s Clinical Research Center at the Hsinchu Biomedical Science Park.
  • 2013
    • UBP was established through spinoff from its parent company United Biomedical, Asia
  • 1998
    • Dr. Wang back to Taiwan and established United Biomedical, Asia
  • 1985
    • Mother company was founded by Dr. Chang Yi Wang and Nean Hu in New York

Copyright © 2022 UNITED BIOPHARMA.

All Rights Reserved

Please Enable cookies to improve your user experience

This website uses cookies to provide a better browsing experience.To learn more about how cookies are used on this website, please click here.